Peptides, antibodies thereto, and their use in the treatment of central nervous system damage

Details for Australian Patent Application No. 2003288434 (hide)

Owner Jiangsu Novavac Bio-tec Co., LTD.

Inventors Xiao, Zhi-Cheng

Agent FB Rice

Pub. Number AU-B-2003288434

PCT Number PCT/GB2003/0053

PCT Pub. Number WO2004/052922

Priority 60/431,620 06.12.02 US

Filing date 5 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 17 March 2011

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/431,620 06.12.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003288434

20 May 2010 Assignment before Grant

  Singapore General Hospital Pte Ltd. The application has been assigned to Cheng, Xiao

30 September 2010 Assignment before Grant

  Cheng, Xiao The application has been assigned to Jiangsu Novavac Bio-tec Co., LTD. 2005

17 March 2011 Application Accepted

  Published as AU-B-2003288434

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003288435-Method of and system for heuristically detecting viruses in executable code

2003288433-Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide